GE HealthCare Technologies Inc. $GEHC Shares Acquired by Vanguard Group Inc.

Key Points

• Vanguard Group boosted its Q4 holding in GE HealthCare by 0.5% to 52,275,767 shares, representing a 11.48% stake worth about $4.29 billion.
• GE HealthCare beat quarterly estimates with $1.44 EPS (vs. $1.40) and $5.70B revenue (vs. $5.60B), reported 7.1% revenue growth, and set FY2026 guidance of $4.95–$5.15 EPS (analysts expect ~5 EPS).
• The company declared a quarterly dividend of $0.035 (annualized $0.14, ~0.2% yield) payable May 15, while Street coverage averages to a "Hold" rating with an average price target of $89.77.

Vanguard Group Inc. boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 0.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 52,275,767 shares of the company's stock after buying an additional 267,058 shares during the quarter. Vanguard Group Inc. owned 11.48% of GE HealthCare Technologies worth $4,287,658,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in GEHC. E Fund Management Hong Kong Co. Ltd. grew its position in GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company's stock worth $26,000 after buying an additional 196 shares during the last quarter. Godsey & Gibb Inc. purchased a new position in GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Optima Capital LLC purchased a new position in GE HealthCare Technologies during the 4th quarter worth approximately $27,000. Maseco LLP purchased a new position in GE HealthCare Technologies during the 4th quarter worth approximately $29,000. Finally, Oakworth Capital Inc. grew its position in GE HealthCare Technologies by 1,876.2% during the 3rd quarter. Oakworth Capital Inc. now owns 415 shares of the company's stock worth $31,000 after purchasing an additional 394 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Stock Up 2.4%

GEHC stock opened at $70.48 on Tuesday. The firm has a market cap of $32.16 billion, a PE ratio of 15.46, a PEG ratio of 1.52 and a beta of 1.17. GE HealthCare Technologies Inc. has a 1 year low of $66.95 and a 1 year high of $89.77. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. The company has a fifty day simple moving average of $74.45 and a 200 day simple moving average of $77.78.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business's quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 5 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.07%.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the stock. Bank of America lifted their price objective on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a "neutral" rating in a research report on Monday, January 5th. Mizuho decreased their target price on shares of GE HealthCare Technologies from $95.00 to $90.00 and set an "outperform" rating for the company in a research note on Monday, April 13th. Wall Street Zen lowered shares of GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research note on Saturday, March 21st. Stifel Nicolaus lifted their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company a "buy" rating in a research note on Wednesday, February 4th. Finally, Piper Sandler decreased their target price on shares of GE HealthCare Technologies from $96.00 to $88.00 and set an "overweight" rating for the company in a research note on Friday, April 17th. Eight analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, GE HealthCare Technologies has an average rating of "Hold" and an average price target of $89.77.

About GE HealthCare Technologies

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.